Printer Friendly

Veteran Pharmaceutical Commercial Strategy Expert Hensley Evans Joins the HealthPrize Technologies Board of Directors.

Norwalk, CT, November 01, 2017 --(PR.com)-- ZS Associates Principal Hensley Evans is joining the board of directors at HealthPrize Technologies, the adherence and patient engagement technology provider announced today.

"Hensley's knowledge and expansive experience in shaping how pharmaceutical brands engage and market to patients is unparalleled," said Tom Kottler, Co-founder and CEO of HealthPrize. "Her insights and counsel will be of immense value to HealthPrize as we accelerate growth in 2018."

Evans, a trailblazer in digital marketing in the pharmaceutical industry, has led strategy for numerous high-profile digital programs for clients such as Johnson & Johnson, Abbvie, Pfizer, Eli Lilly and Novartis, as well as consumer products such as Diet Coke, Prilosec OTC and Claritin. She has held executive and senior management roles at Saatchi & Saatchi, imc2 Health and Wellness, Harte-Hanks Interactive, Andersen Consulting and PriceWaterhouseCoopers.

"I've seen HealthPrize evolve over the past seven years from an innovative startup into one of pharma's most effective models for engaging patients," said Evans. "I look forward to sharing my expertise with the company as it continues its evolution into the industry standard for digital patient engagement."

Life science companies worldwide use HealthPrize's technology to develop digital patient experiences that improve adherence, increase health literacy, and provide brand differentiation. The company's gamification- and behavioral economics-based platform powers and advances patient engagement for branded and generic medications across all therapeutic areas, demographics and drug delivery methods.

About HealthPrize Technologies: HealthPrize Technologies enables life science companies to engage and motivate their customers using gamification, education, behavioral economics and incentives. The company's proven approach results in measurable outcomes across all therapeutic areas, demographics and geographies to deliver the greatest prize of all - better health. Learn more at HealthPrize.com or follow @HealthPrize on Twitter.

Contact Information:

HealthPrize Technologies

Vishal Khanna

336-251-2560

Contact via Email

healthprize.com

Read the full story here: https://www.pr.com/press-release/734565

COPYRIGHT 2017 PR.com
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR.com (Press Releases)
Date:Nov 1, 2017
Words:311
Previous Article:Cell Therapy & Stem Cell Research 2018.
Next Article:North Florida Land Trust Honors City Council Member with the Robert and Merial Milam Conservation Award.
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |